https://www.mijngezondheidsgids.nl/overige/medicatie/het-vertrouwen-in-biosimilars-moet-groeien/
Oct 28, 2020 - Langzaam maar zeker veroveren biosimilars Nederland. Nu medicijnen voor grote patiëntengroepen uit patent komen, verschijnen biosimilars op de markt. Dat...
vertrouwenbiosimilarsmoet
https://www.grandviewresearch.com/industry-analysis/biosimilars-market
Biosimilars market size was estimated at $39.59 billion in 2025, is projected to reach $151.58 billion by 2033, growing at a CAGR of 18.44% from 2026 to 2033
industry reportbiosimilarsmarketsizeshare
https://www.drugdiscoverytrends.com/what-sets-oncology-biosimilars-apart-anticipating-key-challenges-in-the-development-landscape/
Sep 1, 2025 - Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.
key challengessetsoncologybiosimilarsapart
https://www.iqvia.com/de-de/locations/germany/publikationen/fokus-biosimilars
Zu den spannendsten Fragen rund um die Healthcare-Branche national wie global veröffentlicht IQVIA Whitepaper in deutscher und englischer Sprache.
fokusbiosimilars
https://globalbiosimilarsweek.org/2025/
Sep 29, 2025 - IGBA will be hosting the 6th annual Global Biosimilars Week from 3-7 November 2025. This social media campaign aims to raise awareness of the powerful impact...
globalbiosimilarsweek
https://www.pacificresearch.org/biosimilars/
Dec 2, 2024 - WEBINAR The Biosimilar Promise: How Biosimilars Reform Could Save Patients and Taxpayers Even More Low-cost biosimilars generated $19 billion in savings value...
pacific researchbiosimilarsinstitute
https://alliant.com/news-resources/benefits-capturing-savings-from-biosimilars-what-to-do-now/
Biosimilars offer the same therapeutic benefits as brand-name biologics, but they cost an average of 40% less. To take advantage of these savings, employers...
capturingsavingsbiosimilarsalliant
https://trialmed.com/specialist-areas/biosimilars/
Apr 16, 2025 - Biosimilars Many patients worldwide find costly biologics beyond their reach, creating a growing need for effective and potentially less expensive
biosimilars
https://www.abbott.com/corpnewsroom/products-and-innovation/what-are-biologic-medicines-and-biosimilars.html
Biologic medicine can make life-saving treatments more accessible worldwide. Abbott biosimilars mimic biologics to bring these innovations to more people.
medicinesbiosimilarsabbottnewsroom
https://www.biogen.at/ueber-uns/forschung-and-innovation/biosimilars.html
Wir bei Biogen sind überzeugt, dass Biosimilars eine zentrale Rolle bei der Sicherung zukünftiger Innovation im Gesundheitswesen spielen. Biosimilars können...
biosimilars
https://www.healio.com/news/hematology-oncology/resources/biosimilar-rc
A primer for U.S. physicians on the role of biosimilars in medical treatment.
united statesbiosimilars
https://clarivate.com/life-sciences-healthcare/portfolio-strategy/market-assessment/biosimilars/
Assess the market size for biosimilars, optimize your market access strategy and determine how to best position your brand with comprehensive intelligence.
market insightsbiosimilarsclarivate
https://www.biogen.nl/bedrijf/wetenschap-en-innovatie/biosimilars.html
Biogen is van mening dat biosimilars cruciaal zijn voor het veiligstellen van toekomstige innovaties binnen de gezondheidszorg. Biosimilars kunnen een deel van...
biosimilars
https://www.biogen.de/content/corporate/europe/germany/de-de/forschung-und-innovation/biosimilars.html
Wir bei Biogen sind davon überzeugt, dass Biosimilars für die Nachhaltigkeit von Gesundheitssystemen ausgesprochen wichtig sind.
biosimilars
https://reports.statnews.com/collections/all-reports/products/biosimilars-what-will-it-take-to-deliver-on-their-promise
Biosimilars have been heralded as a salve for the skyrocketing costs of prescription medications. But so far they have been a disappointment. In this report,...
biosimilarstakedeliverpromise
https://www.iqvia.com/solutions/therapeutics/biosimilars
Bring your biosimilar to market faster by tapping into unparalleled data, technology, advanced analytics, and scientific expertise.
biosimilars